UMIN ID: UMIN000054106
Registered date:12/04/2024
Retrospective observational study of patients with atopic dermatitis in remission with Upadacitinib.
Basic Information
Recruitment status | Pending |
---|---|
Health condition(s) or Problem(s) studied | Atopic Dermatitis |
Date of first enrollment | 2024/04/20 |
Target sample size | 300 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Remission maintenance rate at 1 year after achieving remission with Upadacitinib |
---|---|
Secondary Outcome | Upadacitinib for atopic dermatitis: the actual treatment of atopic dermatitis. |
Key inclusion & exclusion criteria
Age minimum | 12years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1) Cases of use clearly off-label for Upadacitinib 2) Patients who have requested to refuse to participate in the study |
Related Information
Primary Sponsor | Non-Profit Organization Health Institute Research of Skin |
---|---|
Secondary Sponsor | Abbvie LLC. |
Source(s) of Monetary Support | Non-Profit Organization Health Institute Research of Skin,Abbvie LLC. |
Secondary ID(s) |
Contact
public contact | |
Name | RYOICHI TAGUCHI |
Address | Shibamatsuobiru 4F, 2-9-1 Shibakoen, Minato-ku, Tokyo-to Japan 1050011 |
Telephone | 0364353833 |
ryoichi_taguchi@ebc-m.com | |
Affiliation | EBC&M LLC Clinical Division |
scientific contact | |
Name | YUICHIRO TSUNEMI |
Address | 38 Morohongo, Moroyama-cho, Iruma-gun, Saitama Japan |
Telephone | 049-276-1111 |
cr-info@ebc-m.com | |
Affiliation | Saitama Medical University Hospital Department of Dermatology |